Experienced in Thoracic Aortic Aneurysm

Laurent Y. Chiche

6, Rue Désirée Clary, 
Marseille, FR 
Experienced in Thoracic Aortic Aneurysm
6, Rue Désirée Clary, 
Marseille, FR 
OverviewLocationsClinical Research

Overview

Laurent Chiche practices in Marseille, France. Mr. Chiche is rated as an Experienced expert by MediFind in the treatment of Thoracic Aortic Aneurysm. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, Lupus Nephritis, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Thoracic Aortic Aneurysm.

Gender
Male

Locations

6, Rue Désirée Clary, Marseille, 13000, France
Other Locations
Paris, France
Bordeaux, France
France
1, Avenue De Magellan, Pessac-sur-dordogne, 33600, France
191, Avenue Du Doyen Gaston Giraud, 34925 Montpellier Cedex 5, Montpellier, 34925, France
Caen, France
1208, Avenue Du Colonel Picot, Toulon, 83056, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Detection of Small Fiber Neuropathies by the Non-invasive SUDOSCAN Method During Chronic Autoimmune Pathologies and / or Unexplained Pain Syndromes
Detection of Small Fiber Neuropathies by the Non-invasive SUDOSCAN Method During Chronic Autoimmune Pathologies and / or Unexplained Pain Syndromes
Enrollment Status: Completed
Publish Date: September 25, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

242 Total Publications

Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus
Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus
Journal: La Revue de medecine interne
Published: September 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chiche's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 64 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile